Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-5 of 5
Keywords: Extrinsic pathway inhibitor
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Physiological Role of Vessel Wall Related Antithrombotic Mechanisms: Contribution of Endogenous and Exogenous Heparin-Like Components to the Anticoagulant Potential of the Endothelium
Available to Purchase
Pathophysiology of Haemostasis and Thrombosis (1990) 20 (Suppl. 1): 30–49.
Published Online: 24 April 2009
... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Endothelium Anticoagulants Prostacyclin Vascular anticoagulant Extrinsic pathway inhibitor Glycosaminoglycans...
Journal Articles
Anticoagulant Potential of Endothelial Cell Membrane Components
Available to Purchase
Pathophysiology of Haemostasis and Thrombosis (1988) 18 (4-6): 271–306.
Published Online: 24 April 2009
..., is believed to be a major event in the induction of anticoagulatory mechanisms such as the protein C/protein S system which warrant a balanced hemostatic system. Additional components such as vascular anticoagulant or extrinsic pathway inhibitor may also contribute to the anticoagulant potential of the vessel...
Journal Articles
Extrinsic Pathway Inhibitor in Postoperative/Posttraumatic Septicemia: Increased Levels in Fatal Cases
Available to Purchase
Pathophysiology of Haemostasis and Thrombosis (1989) 19 (4): 189–195.
Published Online: 24 April 2009
...Per Morten Sandset; Olav Røise; Ansgar O. Aasen; Ulrich Abildgaard The activity of the extrinsic pathway inhibitor (EPI), which is the factor-Xa-dependent inhibitor of the factor Vila-tissue thromboplastin complex, was serially determined in 13 patients with postoperative/posttraumatic septicemia...
Journal Articles
Extrinsic Pathway Inhibitor – The Key to Feedback Control of Blood Coagulation Initiated by Tissue Thromboplastin
Available to Purchase
Pathophysiology of Haemostasis and Thrombosis (1991) 21 (4): 219–239.
Published Online: 24 April 2009
...Per Morten Sandset; Ulrich Abildgaard Extrinsic pathway inhibitor (EPI) is a Kunitz type serine protease inhibitor. EPI is a potent inhibitor of the factor VIIa/thromboplastin (TP) complex in the presence of factor Xa and is also a direct inhibitor of factor Xa. The inhibitory mechanism is complex...
Journal Articles
Heparin Requires both Antithrombin and Extrinsic Pathway Inhibitor for Its Anticoagulant Effect in Human Blood
Available to Purchase
Pathophysiology of Haemostasis and Thrombosis (1991) 21 (4): 254–257.
Published Online: 24 April 2009
...%, respectively, of control values in nonheparinized blood. When monospecific, neutralizing IgG against extrinsic pathway inhibitor (anti-EPI) were added to heparinized blood prior to TP, the amount of FPA increased to 65%. When monospecific IgG blocking antithrombin (anti-AT) was used, the amount of FPA...